Chemotherapeutic Antibiotics: Cell Wall Inhibition (DONE) Flashcards

1
Q

Why is there a need for new antibiotics?

A

Only 10-15 targets

Resistance is inevitable and now a major concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peptidoglycan in cell wall synthesis

A

Peptidoglycan is an essential wall polymer, responsible for shape and integrity, unique in prokaryotes
Interference with its synthesis or structure leads to loss of cell shape and integrity followed by bacterial death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is peptidoglycan made of?

A

Contains chains of alternating N-acetylmuramic acid and N-acetylglucosamine residues, cross-linked through pentapeptide side chains attached to MurNAc
The pentapeptide side chain sequence is L-Ala (occasionally L-Gly): D-Glu-X-D-Ala-D-Ala
Where X is usually a diamino acid and most often meso-diaminopimelic acid or L-Lys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Biosynthesis of peptidoglycan (overview)

A

Synthesis of precursors in the cytoplasm, or at the inner surface of the cytoplasmic membrane
Transfer across the cytoplasmic membrane
Polymerization on the outer surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cell wall synthesis stage 1

A

Assembly of the disaccharide-peptide monomer unit by enzymes located in the cytoplasm, or at the inner surface of the cytoplasmic membrane
Synthesis of cytoplasmic cell wall precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cell wall synthesis stage 2

A

Transfer of the monomer unit across the cytoplasmic membrane

Synthesis of wall subunit attached to lipid carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cell wall synthesis stage 3

A

Polymerization of the monomer unit on the outer surface of the membrane and concomitant binding of the nascent peptidoglycan to the pre-existing cell wall
Polymerisation of glycan and attachment to wall by transpeptidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cell wall inhibition

A

Steps in the final stage of bacterial peptidoglycan synthesis have been extensively exploited as drug targets through the development of B-lactams and glycopeptides
In contrast, only some of the many biosynthetic steps in stages one and two are the targets of antibiotics in current clinical use (D-cycloserine, fosfomycin, bacitracin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cell wall inhibition- beta lactams

A

Penicillin V, penicillin G
Bactericidal action against growing and dividing bacteria
Inhibit the final cross linking stage of the peptidoglycan production, binding to and inactivating transpeptidases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Autolysin

A

Penicillin treated bacteria grown in an isotonic media survive, cell lysis caused by inactivation of inhibitors of autolysins
Autolysin: an enzyme that hydrolyses and breaks down the components of a biological cell, present in all bacteria that have a peptidoglycan
Hydrolyses the B 1,4 bond between N-acetylmuramic acid and N-acetylglucosamine molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications of penicillin V

A

Oral infections, tonsillitis, otitis media, pneumococcal infection prophylaxis
Dose e.g. 500mg every 6 hours (1g/6h in severe infection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications of ampicillin (broad spectrum)

A

UTI, otitis media, sinusitis, oral infections, bronchitis, influenza infections, invasive salmonellosis, listeria meningitis
Dose e.g. 0.25-1g every 6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indications of amoxicillin (broad spectrum)

A

UTI, otitis media, sinusitis, oral infections, bronchitis, influenza infections, invasive salmonellosis, listeria meningitis, endocarditis prophylaxis and treatment, anthrax, H pylori eradication
Dose e.g. 250mg/8 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Combinations of broad spectrum penicillins

A

Co-amoxiclav: amoxicillin and clavulanic acid, use against B lactamase producing strains, RTI, genito-urinary and abdominal infections, cellulitis
Co-fluampicil: flucloxacillin and ampicillin, use against B-lactamase producing staphylococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anti-pseudomonal penicillins

A

Piperacillin: infection with Ps aeruginosa, LRI, UTI, intra-abdominal and skin infections, septicaemia
Dose e.g. infusion 2.25g/6-8h
Amoxicillin: severe infections with pseudomonas and proteus spp. and bacteroides fragilis
Dose e.g. 3.2g/ 6-8h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cephalosporins

A

Cefalexin: UTI, RTI, otitis media and sinusitis, skin and soft tissue infection, dose e.g. 250mg/6h
Cefradine: UTI, RTI, otitis media and sinusitis, skin and soft tissue infection, surgical prophylaxis, dose e.g. 250-500mg/6h

17
Q

Second generation cephalosporins- cephaclor and cefuroxime

A

Cephaclor: UTI, RTI, otitis media and sinusitis, skin and soft tissue infection, dose e.g. 250mg/8h
Cefuroxime: UTI, RTI, otitis media, sinusitis, skin and soft tissue infection, surgical prophylaxis, lyme disease, dose e.g. 250mg twice daily

18
Q

Second generation cephalosporins- cefixime, cefotaxime, ceftazidime

A

Cefixime: UTI, RTI, otitis media and sinusitis, skin and soft tissue infection, dose e.g. 200-400mg daily
Cefotaxime: UTI, RTI, otitis media, sinusitis, skin and soft tissue infection, gonorrhoea, surgical prophylaxis, dose e.g. injection 1g/12h
Ceftazidime: broad spectrum, increased activity compared to second generation cephalosporin against gram negative, UTI, RTI, otitis media, sinusitis, skin and soft tissue infection, dos e.g. injection 1g/8h

19
Q

Monobactam

A

Aztreonam: monocyclic B-lactam
Inactivated by extended spectrum B-lactamases
Indications: gram negative bacteria including Ps aeruginosa, H influanzae
Dose e.g. injection 1g/8h

20
Q

Penems

A

Broad spectrum activity including aerobic and anaerobic bacteria
Imipenem: aerobic and anaerobic bacteria, surgical prophylaxis, septicaemia, dose e.g. injection 1-2g daily
Meropenem: aerobic and anaerobic bacteria, dose e.g. 500mg/8h
Ertapenem: abdominal infections, acute gynae infections, CA-pneumonia, diabetic foot infections, prophylaxis colorectal surgery, dose e.g. infusion 1g daily

21
Q

Cell wall inhibition- glycoepeptides: vancomycin

A

Bactericidal against gram positive aerobes and anaerobes including MDR staphylococci
Inhibition of peptidoglycan synthesis by inhibiting transglycosylase which produces linear strands of peptidoglycan
Prevent the transfer and addition of muramyl-pentapeptide building blocks
Indications: endocarditic, gram positive infections, peritonitis, dose e.g. 1g /12h

22
Q

Cell wall inhibition: bacitracin and bacitracin zinc

A

Interferes with bacterial cell wall synthesis

Blocks the function of the lipid carrier molecule that transfers cell wall subunit across the cell membrane

23
Q

D-cycloserine

A

Antimycobacterial

Compete with D-alanine for incorporation in the cell wall